Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Orbactiv“
Suchtreffer
Begriffe & Kennungen
Tenkasi (previously Orbactiv)
Eintrag öffnenTenkasi (previously Orbactiv) · 4.1 Therapeutic indications · 1
Eintrag öffnenTenkasi (previously Orbactiv) · 4.1 Therapeutic indications · 2
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 Contraindications · 1
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 Contraindications · 2
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 · Use of intravenous unfractionated heparin sodium is contraindicated for 120 hours (5 days) after oritavancin a
Eintrag öffnenTenkasi (previously Orbactiv) · 4.3 · Use of intravenous unfractionated heparin sodium is contraindicated for 120 hours (5 days) after oritavancin a
Eintrag öffnenTenkasi (previously Orbactiv) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenTenkasi (previously Orbactiv) · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · 5 A screening drug-drug interaction study was conducted in healthy volunteers (n=16) evaluating the concomitan
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · A screening drug-drug interaction study was conducted in healthy volunteers (n=16) evaluating the concomitant
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Caution should be used when administering oritavancin concomitantly with medicinal products with a narrow ther
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Caution should be used when administering oritavancin concomitantly with medicinal products with a narrow ther
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Drug-laboratory test interactions (see sections 4.3 and 4.4)
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Drug-laboratory test interactions (see sections 4.3 and 4.4)
Eintrag öffnenTenkasi (previously Orbactiv) · 4.5 · Oritavancin binds to and prevents the action of the phospholipid reagents which activate coagulation in common
Eintrag öffnen